Molecular Medicine Tri-Conference
The company sees microRNAs as the ideal blood-based biomarker for diagnosing and monitoring a number of diseases at the point of care and in the developing world.
Precision for Medicine Launches PATH to Help Stratify Patients for Personalized Medicine Studies
PATH is designed to help users combine and use clinical and genomic information to stratify patients as part of efforts to develop more tailored therapies.
Elsevier, Maverix Ink Software Integration Agreement
Under the terms of the agreement, the companies will combine software products and data to improve NGS analysis and interpretation
Singapore's MiRxes Spins Out from A*Star with Novel qPCR Assay Platform for microRNA Analysis
MiRxes, a Singapore-based startup focusing on microRNA research and diagnostics, officially launched earlier this month with a proprietary qPCR platform for identifying microRNA and other small RNA biomarkers.
UCSF, QB3 Team Developing PCR-Activated Cell Sorting Method; Startup Mission Bio Eyes Market
Researchers from the University of California, San Francisco and the California Institute for Quantitative Biosciences have developed a method dubbed PCR-activated cell sorting (PACS) to sort and analyze single cells from large populations of heterogeneous cells based on gene exp